{"id":"NCT04305405","sponsor":"AstraZeneca","briefTitle":"PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma","officialTitle":"An Open-label Study to Evaluate the Pharmacokinetics and Pharmacodynamics and Long-term Safety of Benralizumab Administered Subcutaneously in Children With Severe Eosinophilic Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-11-21","primaryCompletion":"2022-09-12","completion":"2022-09-12","firstPosted":"2020-03-12","resultsPosted":"2023-05-18","lastUpdate":"2023-05-18"},"enrollment":30,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"BASIC_SCIENCE"},"conditions":["Severe Uncontrolled Asthma"],"interventions":[{"type":"DRUG","name":"Benralizumab","otherNames":[]}],"arms":[{"label":"Dose 1","type":"EXPERIMENTAL"},{"label":"Dose 2","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the PK, PD and long-term safety of Benralizumab administered subcutaneously in 30 children aged 6 to 11 years with severe eosinophilic asthma. Up to an additional 3 Japanese patients aged 12 to 14 years will be enrolled to meet local regulatory requirements.","primaryOutcome":{"measure":"Clearance of Benralizumab","timeFrame":"Pre-dose on Days 0, 28, 56, 112, 168 and post-dose on Days 1, 7, 14, 84, 336; and at early discontinuation or withdrawal visit","effectByArm":[{"arm":"All Participants","deltaMin":0.156,"sd":0.0598}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":15,"countries":["United States","Japan"]},"refs":{"pmids":["38491795"],"seeAlso":["https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D3250C00025&amp;attachmentIdentifier=293a579d-d532-4748-9486-04e94c6b2b6b&amp;fileName=D3250C00025-clinical-study-report_synopsis_Redacted_PDFA.pdf&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":15},"commonTop":["Nasopharyngitis","Pyrexia","Viral upper respiratory tract infection","COVID-19","Headache"]}}